Matthew P. Blischak

Matt Blischak is the Chief Executive Officer of Finch Therapeutics. Matt has more than 20 years experience as an executive in the life sciences industry with a particular focus on high stakes patent litigation related to multiple blockbuster drugs. He has also been involved in significant licensing, acquisition, collaboration, and litigation settlement agreements over that time. Before joining Finch, Matt served at Roivant Sciences where he focused on the management and protection of intellectual property for the company and its subsidiaries. Matt directed patent enforcement on a global scale for Bristol-Myers Squibb Co., Teva Pharmacueticals, and Sunovion Pharmaceuticals. His legal career began at Cleary, Gottlieb, Steen and Hamilton.

Matt received a bachelor of science in chemical engineering from Case-Western Reserve University, a masters degree in biotechnology from Johns Hopkins University, and a law degree from The American University Washington College of Law.